Literature DB >> 23040337

State of the science: chronic periodontitis and systemic health.

Joan Otomo-Corgel1, Jeffery J Pucher, Michael P Rethman, Mark A Reynolds.   

Abstract

CONTEXT: Inflammatory periodontal diseases exhibit an association with multiple systemic conditions. Currently, there is a lack of consensus among experts on the nature of these associations and confusion among health care providers and the public on how to interpret this rapidly growing body of science. This article overviews the current evidence linking periodontal diseases to diabetes, cardiovascular disease, osteoporosis, preterm low birth weight babies, respiratory diseases, and rheumatoid arthritis. EVIDENCE ACQUISITION: Evidence was taken from systematic reviews, clinical trials, and mechanistic studies retrieved in searches of the PubMed electronic database. The available data provide the basis for applied practical clinical recommendations. EVIDENCE SYNTHESIS: Evidence is summarized and critically reviewed from systematic reviews, primary clinical trials, and mechanistic studies
CONCLUSIONS: Surrogate markers for chronic periodontitis, such as tooth loss, show relatively consistent but weak associations with multiple systemic conditions. Despite biological plausibility, shorter-term interventional trials have generally not supported unambiguous cause-and-effect relationships. Nevertheless, the effective treatment of periodontal infections is important to achieve oral health goals, as well as to reduce the systemic risks of chronic local inflammation and bacteremias. Inflammatory periodontal diseases exhibit an association with multiple systemic conditions. With pregnancy as a possible exception, the local and systemic effects of periodontal infections and inflammation are usually exerted for many years, typically among those who are middle-aged or older. It follows that numerous epidemiological associations linking chronic periodontitis to age-associated and biologically complex conditions such as diabetes, cardiovascular disease, osteoporosis, respiratory diseases, rheumatoid arthritis, certain cancers, erectile dysfunction, kidney disease and dementia, have been reported. In the coming years, it seems likely that additional associations will be reported, despite adjustments for known genetic, behavioral and environmental confounders. Determining cause-and-effect mechanisms is more complicated, especially in circumstances where systemic effects may be subtle. Currently, however, there is a lack of consensus among experts on the nature of these associations and confusion among health care providers and the public on how to interpret this rapidly growing body of science. This article overviews the current evidence linking periodontal diseases to diabetes, cardiovascular disease, osteoporosis, preterm/low birth weight babies, respiratory diseases, and rheumatoid arthritis.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23040337     DOI: 10.1016/S1532-3382(12)70006-4

Source DB:  PubMed          Journal:  J Evid Based Dent Pract        ISSN: 1532-3382            Impact factor:   5.267


  68 in total

1.  Polymicrobial infection alter inflammatory microRNA in rat salivary glands during periodontal disease.

Authors:  Gautam Nayar; Adrienne Gauna; Sasanka Chukkapalli; Irina Velsko; Lakshmyya Kesavalu; Seunghee Cha
Journal:  Anaerobe       Date:  2015-10-22       Impact factor: 3.331

Review 2.  Microbiota, oral microbiome, and pancreatic cancer.

Authors:  Dominique S Michaud; Jacques Izard
Journal:  Cancer J       Date:  2014 May-Jun       Impact factor: 3.360

3.  Secretory IgA reactivity to social threat in youth: Relations with HPA, ANS, and behavior.

Authors:  Heidemarie K Laurent; Laura R Stroud; Bridget Brush; Christina D'Angelo; Douglas A Granger
Journal:  Psychoneuroendocrinology       Date:  2015-05-21       Impact factor: 4.905

4.  Bacterial infection increases periodontal bone loss in diabetic rats through enhanced apoptosis.

Authors:  Sandra Pacios; Oelisoa Andriankaja; Jun Kang; Maher Alnammary; Jason Bae; Beatriz de Brito Bezerra; Helen Schreiner; Daniel H Fine; Dana T Graves
Journal:  Am J Pathol       Date:  2013-10-08       Impact factor: 4.307

5.  Human oral microbiome and prospective risk for pancreatic cancer: a population-based nested case-control study.

Authors:  Xiaozhou Fan; Alexander V Alekseyenko; Jing Wu; Brandilyn A Peters; Eric J Jacobs; Susan M Gapstur; Mark P Purdue; Christian C Abnet; Rachael Stolzenberg-Solomon; George Miller; Jacques Ravel; Richard B Hayes; Jiyoung Ahn
Journal:  Gut       Date:  2016-10-14       Impact factor: 23.059

6.  Rheumatoid arthritis - an update for general dental practitioners.

Authors:  S de Souza; R K Bansal; J Galloway
Journal:  Br Dent J       Date:  2016-11-18       Impact factor: 1.626

Review 7.  Microbiota dysbiosis in select human cancers: Evidence of association and causality.

Authors:  Jie Chen; Jada C Domingue; Cynthia L Sears
Journal:  Semin Immunol       Date:  2017-08-16       Impact factor: 11.130

8.  Association between Medicaid expansion, dental coverage policies for adults, and children's receipt of preventive dental services.

Authors:  Tumader Khouja; Jacqueline M Burgette; Julie M Donohue; Eric T Roberts
Journal:  Health Serv Res       Date:  2020-07-22       Impact factor: 3.402

9.  Factors associated with regular dental visits among hemodialysis patients.

Authors:  Masami Yoshioka; Yasuhiko Shirayama; Issei Imoto; Daisuke Hinode; Shizuko Yanagisawa; Yuko Takeuchi; Takashi Bando; Narushi Yokota
Journal:  World J Nephrol       Date:  2016-09-06

10.  The activity of bacterial peptidylarginine deiminase is important during formation of dual-species biofilm by periodontal pathogen Porphyromonas gingivalis and opportunistic fungus Candida albicans.

Authors:  Justyna Karkowska-Kuleta; Dominika Bartnicka; Marcin Zawrotniak; Gabriela Zielinska; Anna Kieronska; Oliwia Bochenska; Izabela Ciaston; Joanna Koziel; Jan Potempa; Zbigniew Baster; Zenon Rajfur; Maria Rapala-Kozik
Journal:  Pathog Dis       Date:  2018-06-01       Impact factor: 3.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.